- Home
- ALLR vs FOXO Comparison
ALLR vs FOXO Comparison
Compare ALLR & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- FOXO
- Stock Information
- Founded
- ALLR 2004
- FOXO 2019
- Country
- ALLR United States
- FOXO United States
- Employees
- ALLR N/A
- FOXO N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- FOXO Retail: Computer Software & Peripheral Equipment
- Sector
- ALLR Health Care
- FOXO Technology
- Exchange
- ALLR Nasdaq
- FOXO Nasdaq
- Market Cap
- ALLR 2.3M
- FOXO 2.4M
- IPO Year
- ALLR N/A
- FOXO N/A
- Fundamental
- Price
- ALLR $1.32
- FOXO $0.67
- Analyst Decision
- ALLR
- FOXO
- Analyst Count
- ALLR 0
- FOXO 0
- Target Price
- ALLR N/A
- FOXO N/A
- AVG Volume (30 Days)
- ALLR 658.4K
- FOXO 142.6M
- Earning Date
- ALLR 11-14-2024
- FOXO 08-19-2024
- Dividend Yield
- ALLR N/A
- FOXO N/A
- EPS Growth
- ALLR N/A
- FOXO N/A
- EPS
- ALLR N/A
- FOXO N/A
- Revenue
- ALLR N/A
- FOXO $155,000.00
- Revenue This Year
- ALLR N/A
- FOXO N/A
- Revenue Next Year
- ALLR N/A
- FOXO N/A
- P/E Ratio
- ALLR N/A
- FOXO N/A
- Revenue Growth
- ALLR N/A
- FOXO N/A
- 52 Week Low
- ALLR $1.26
- FOXO $0.13
- 52 Week High
- ALLR $666.00
- FOXO $1.30
- Technical
- Relative Strength Index (RSI)
- ALLR 32.39
- FOXO 60.53
- Support Level
- ALLR $1.32
- FOXO $0.13
- Resistance Level
- ALLR $1.53
- FOXO $1.30
- Average True Range (ATR)
- ALLR 0.12
- FOXO 0.24
- MACD
- ALLR 0.05
- FOXO 0.05
- Stochastic Oscillator
- ALLR 14.63
- FOXO 46.11
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.